Gmt Capital Corp Royalty Pharma PLC Transaction History
Gmt Capital Corp
- $1.97 Billion
- Q4 2024
A detailed history of Gmt Capital Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Gmt Capital Corp holds 3,267,700 shares of RPRX stock, worth $109 Million. This represents 4.24% of its overall portfolio holdings.
Number of Shares
3,267,700
Previous 3,097,500
5.49%
Holding current value
$109 Million
Previous $87.6 Million
4.87%
% of portfolio
4.24%
Previous 3.57%
Shares
6 transactions
Others Institutions Holding RPRX
# of Institutions
429Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.32 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.25 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$767 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$566 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$471 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...